Log in

Relevant bibliographies by topics / DOPPS / Journal articles

To see the other types of publications on this topic, follow the link: DOPPS.

Journal articles on the topic 'DOPPS'

Author: Grafiati

Published: 4 June 2021

Last updated: 7 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'DOPPS.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sun, Ying-Ping, Wen-Jun Yang, Su-Hua Li, Yuan-yuan Han, and Jian Liu. "Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China." BioMed Research International 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/2516934.

Full text

Abstract:

We investigated the clinical epidemiology of mineral bone disorder markers in prevalent hemodialysis (HD) patients in Xinjiang, the largest province in China. Data were obtained from 59 hospitals. A total of 3725 patients tracked from January 1 to December 31, 2014, were enrolled. Serum calcium (Ca) levels, phosphorus (P) levels, and intact parathyroid hormone (iPTH) levels were analyzed. Serum Ca levels were lower compared to the International Dialysis Outcomes and Practice Patterns Study (DOPPS4) and the Chinese DOPPS. The hypercalcemia rate was similar to DOPPS4 and lower than in the Chines

APA, Harvard, Vancouver, ISO, and other styles

2

Jadoul, M. "KDIGO et DOPPS : quelles perspectives ?" Néphrologie & Thérapeutique 6, no. 5 (2010): 4–6. http://dx.doi.org/10.1016/s1769-7255(10)70024-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ureña-Torres, Pablo, Brian Bieber, Fitsum Guebre-Egziabher, et al. "Citric Acid–Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns Study." Kidney360 2, no. 4 (2021): 666–73. http://dx.doi.org/10.34067/kid.0006182020.

Full text

Abstract:

BackgroundMetabolic acidosis is a common threat for patients on hemodialysis, managed by alkaline dialysate. The main base is bicarbonate, to which small amounts of acetic, citric, or hydrochloric acid are added. The first two are metabolized to bicarbonate, mostly by the liver. Citric acid–containing dialysate might improve dialysis efficiency, anticoagulation, calcification propensity score, and intradialytic hemodynamic stability. However, a recent report from the French dialysis registry suggested this dialysate increases mortality risk. This prompted us to assess whether citric acid–conta

APA, Harvard, Vancouver, ISO, and other styles

4

Cavalli, A., and G. Pontoriero. "Come è cambiata la gestione dell'anemia per i pazienti in dialisi alla luce dello studio DOPPS." Giornale di Clinica Nefrologica e Dialisi 22, no. 4 (2018): 27–33. http://dx.doi.org/10.33393/gcnd.2010.1241.

Full text

Abstract:

L'anemia è una frequente complicanza della malattia renale cronica (Chronic Kidney Disease, o più brevemente CKD) e rappresenta un importante fattore di rischio cardiovascolare che aggrava ulteriormente la prognosi dei pazienti nefropatici. Gli agenti stimolanti l'eritropoiesi (ESA) e la supplementazione marziale rappresentano i cardini su cui attualmente si basa la terapia di questa complicanza della CKD. Il Dialysis Outcomes and Practice Patterns Study (DOPPS) - studio internazionale, prospettico, osservazionale - è stato avviato nel 1996 per raccogliere informazioni riguardanti le pratiche

APA, Harvard, Vancouver, ISO, and other styles

5

Hogan, Michelle. "DOPPS Practice Monitor: TrendsReassuring, but Early." Nephrology Times 5, no. 2 (2012): 7–8. http://dx.doi.org/10.1097/01.nep.0000413139.42355.1c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Cavalli, A., and G. Pontoriero. "Qualità della vita dei pazienti emodializzati alla luce dello studio DOPPS." Giornale di Clinica Nefrologica e Dialisi 23, no. 4 (2018): 60–65. http://dx.doi.org/10.33393/gcnd.2011.1503.

Full text

Abstract:

Il DOPPS (Dialysis Outcomes and Practice Patterns Study) - ampio studio internazionale, prospettico, osservazionale – è iniziato nel 1996 per raccogliere i dati di un vasto campione di pazienti emodializzati con l'obiettivo di migliorare la terapia, la pratica dialitica ed ovviamente la loro qualità di vita. Lo studio DOPPS ha mostrato come i pazienti emodializzati presentino una qualità di vita molto inferiore rispetto ai soggetti di pari età, in tutte le sue diverse componenti (fisica, mentale e legata alla malattia renale cronica), oltre che una maggior prevalenza di sintomatologia depressi

APA, Harvard, Vancouver, ISO, and other styles

7

Zuo, Li, Mia Wang, Fanfan Hou, et al. "Anemia Management in the China Dialysis Outcomes and Practice Patterns Study." Blood Purification 42, no. 1 (2016): 33–43. http://dx.doi.org/10.1159/000442741.

Full text

Abstract:

Background: As the utilization of hemodialysis increases in China, it is critical to examine anemia management. Methods: Using data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), we describe hemoglobin (Hgb) distribution and anemia-related therapies. Results: Twenty one percent of China's DOPPS patients had Hgb <9 g/dl, compared with ≤10% in Japan and North America. A majority of medical directors targeted Hgb ≥11. Patients who were female, younger, or recently hospitalized had higher odds of Hgb <9; those with insurance coverage or on twice weekly dialysis had low

APA, Harvard, Vancouver, ISO, and other styles

8

Pegoraro, M. "Dati DOPPS e dose dialitica: considerazioni assistenziali." Giornale di Tecniche Nefrologiche e Dialitiche 23, no. 2 (2011): 65–69. http://dx.doi.org/10.1177/039493621102300217.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gorke, Alois. "Dialysis Outcomes and Practice Patterns Study (DOPPS)." Dialyse aktuell 20, no. 06 (2016): 274–75. http://dx.doi.org/10.1055/s-0042-110411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pegoraro, M. "Dati DOPPS e dose dialitica: considerazioni assistenziali." Giornale di Clinica Nefrologica e Dialisi 23, no. 2 (2018): 65–69. http://dx.doi.org/10.33393/gcnd.2011.1443.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Cavalli, A., and G. Pontoriero. "Qual è il contributo dello studio DOPPS nel caratterizzare il concetto di dose di dialisi?" Giornale di Clinica Nefrologica e Dialisi 23, no. 2 (2018): 70–76. http://dx.doi.org/10.33393/gcnd.2011.1444.

Full text

Abstract:

La necessità di misurare oggettivamente la dose di dialisi somministrata ai pazienti ha determinato lo sviluppo di parametri utilizzabili per la valutazione dell'adeguatezza della terapia dialitica, di cui il principale è il Kt/V dell'urea (che mette in relazione la quantità di clearance dell'urea fornita al paziente nel tempo t di trattamento dialitico, con il volume di distribuzione dell'urea). Due importanti trial randomizzati (il “National Cooperative Dialysis Study” e l'Hemo Study) hanno valutato la dose di dialisi al fine di stabilire il livello minimo da garantire ai pazienti per evitar

APA, Harvard, Vancouver, ISO, and other styles

12

Hirth, Richard A. "International Economics of Dialysis: Lessons from the DOPPS." Seminars in Dialysis 23, no. 1 (2010): 16–18. http://dx.doi.org/10.1111/j.1525-139x.2009.00678.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Akiba, Takashi, Tadao Akizawa, Shunichi Fukuhara, et al. "Results of the international DOPPS hemodialysis study in Japan." Nihon Toseki Igakkai Zasshi 37, no. 10 (2004): 1865–73. http://dx.doi.org/10.4009/jsdt.37.1865.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Komaba, Hirotaka, Mia Wang, Masatomo Taniguchi, et al. "MP348ADDITION OF SEVELAMER AND MORTALITY: THE WORLDWIDE DOPPS STUDY." Nephrology Dialysis Transplantation 31, suppl_1 (2016): i455. http://dx.doi.org/10.1093/ndt/gfw190.05.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Pegoraro, M. "Gestione dell'anemia e utilizzo di ESA secondo i dati dello studio DOPPS. Revisione dei dati DOPPS e considerazioni infermieristiche e clinico relazionali." Giornale di Clinica Nefrologica e Dialisi 22, no. 4 (2018): 34–37. http://dx.doi.org/10.33393/gcnd.2010.1242.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Ecder, Tevfik, Cengiz Utas, Kenan Ates, et al. "The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey." Hemodialysis International 21, no. 3 (2016): 430–39. http://dx.doi.org/10.1111/hdi.12504.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Cavalli, A., and G. Pontoriero. "Qualità della vita dei pazienti emodializzati alla luce dello studio DOPPS." Giornale di Tecniche Nefrologiche e Dialitiche 23, no. 4 (2011): 60–65. http://dx.doi.org/10.1177/039493621102300414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Fuller, D. S., R. L. Pisoni, D. M. Dykstra, et al. "95 DOPPS Practice Monitor Facility Sample Represents Overall US Hemodialysis Population." American Journal of Kidney Diseases 57, no. 4 (2011): B40. http://dx.doi.org/10.1053/j.ajkd.2011.02.098.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Pifer, Trinh B., Keith P. Mccullough, Friedrich K. Port, et al. "Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS." Kidney International 62, no. 6 (2002): 2238–45. http://dx.doi.org/10.1046/j.1523-1755.2002.00658.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Podjed, Dan. "Skupnizacija kot seštevek skupnosti in organizacije: Primer ornitološkega in naravovarstvenega društva." Ars & Humanitas 8, no. 1 (2014): 99–117. http://dx.doi.org/10.4312/ah.8.1.99-117.

Full text

Abstract:

Prispevek, ki je nastal na podlagi etnografske raziskave, osvetli dinamiko razmerij v slovenskem ornitološkem in naravovarstvenem društvu DOPPS, v katerem se prepletajo prostovoljske in profesionalne dejavnosti. Na primeru društva prikaže konfliktna razmerja med skupinami, hkrati pa opiše recipročnost in sodelovanje ter poenotenje kulturnih predpostavk, ki so pomembne za doseganje skupnih ciljev. Avtor ugotavlja, da nestabilna in nasprotujoča si razmerja v društvu utemeljujejo nenavaden preplet med hierarhično organizacijo in egalitarno skupnostjo, ki jo britanski socialni antropolog Martin Pa

APA, Harvard, Vancouver, ISO, and other styles

21

Podjed, Dan. "Skupnizacija kot seštevek skupnosti in organizacije: Primer ornitološkega in naravovarstvenega društva." Ars & Humanitas 8, no. 1 (2014): 99–117. http://dx.doi.org/10.4312/ars.8.1.99-117.

Full text

Abstract:

Prispevek, ki je nastal na podlagi etnografske raziskave, osvetli dinamiko razmerij v slovenskem ornitološkem in naravovarstvenem društvu DOPPS, v katerem se prepletajo prostovoljske in profesionalne dejavnosti. Na primeru društva prikaže konfliktna razmerja med skupinami, hkrati pa opiše recipročnost in sodelovanje ter poenotenje kulturnih predpostavk, ki so pomembne za doseganje skupnih ciljev. Avtor ugotavlja, da nestabilna in nasprotujoča si razmerja v društvu utemeljujejo nenavaden preplet med hierarhično organizacijo in egalitarno skupnostjo, ki jo britanski socialni antropolog Martin Pa

APA, Harvard, Vancouver, ISO, and other styles

22

Kimata, Naoki, Ken Tsuchiya, Takashi Akiba, and Kosaku Nitta. "Differences in the Characteristics of Dialysis Patients in Japan Compared with Those in Other Countries." Blood Purification 40, no. 4 (2015): 275–79. http://dx.doi.org/10.1159/000441573.

Full text

Abstract:

Background: Japanese patients undergoing dialysis have an extremely low mortality rate compared with those in the United States and Europe. As shown in the Dialysis Outcomes & Practice Patterns Study (DOPPS), certain features of dialysis treatment, such as single treatment time and amount of blood flow, are unique to Japan, but factors contributing to the low mortality risk are unclear. Although DOPPS is a multi-country prospective cohort study, the study results may not entirely reflect the real trend in Japan because the number of Japanese institutions participating in the study is small

APA, Harvard, Vancouver, ISO, and other styles

23

Pegoraro, M. "Gestione dell'anemia e utilizzo di ESA secondo i dati dello studio DOPPS." Giornale di Tecniche Nefrologiche e Dialitiche 22, no. 4 (2010): 34–37. http://dx.doi.org/10.1177/039493621002200409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bailie, George R., Nancy A. Mason, Jennifer L. Bragg-Gresham, Brenda W. Gillespie, and Eric W. Young. "Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription." Kidney International 65, no. 6 (2004): 2419–25. http://dx.doi.org/10.1111/j.1523-1755.2004.00658.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Iseki, Kunitoshi, Kazuhiko Tsuruya, Eiichiro Kanda, Takanobu Nomura, and Hideki Hirakata. "Effects of Sleepiness on Survival in Japanese Hemodialysis Patients: J-DOPPS Study." Nephron Clinical Practice 128, no. 3-4 (2015): 333–40. http://dx.doi.org/10.1159/000366479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Port, Friedrich K., Robert A. Wolfe, Philip J. Held, and Eric W. Young. "Random Sample (DOPPS) versus Census-Based (Registry) Approaches to Kidney Disease Research." Blood Purification 21, no. 1 (2003): 85–88. http://dx.doi.org/10.1159/000067859.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Robinson, Bruce M., Douglas S. Fuller, Brian A. Bieber, Marc N. Turenne, and Ronald L. Pisoni. "The DOPPS Practice Monitor for US Dialysis Care: Trends Through April 2011." American Journal of Kidney Diseases 59, no. 2 (2012): 309–12. http://dx.doi.org/10.1053/j.ajkd.2011.11.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Pisoni, Ronald L., Douglas S. Fuller, Brian A. Bieber, Brenda W. Gillespie, and Bruce M. Robinson. "The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011." American Journal of Kidney Diseases 60, no. 1 (2012): 160–65. http://dx.doi.org/10.1053/j.ajkd.2012.04.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Fuller, Douglas S., Ronald L. Pisoni, Brian A. Bieber, Brenda W. Gillespie, and Bruce M. Robinson. "The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011." American Journal of Kidney Diseases 61, no. 2 (2013): 342–46. http://dx.doi.org/10.1053/j.ajkd.2012.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Young, Eric W., David A. Goodkin, Donna L. Mapes, et al. "The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study." Kidney International 57 (January 2000): S74—S81. http://dx.doi.org/10.1046/j.1523-1755.2000.07413.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Tiboni, Mattia, Sofia Coppari, Luca Casettari, et al. "Prunus spinosa Extract Loaded in Biomimetic Nanoparticles Evokes In Vitro Anti-Inflammatory and Wound Healing Activities." Nanomaterials 11, no. 1 (2020): 36. http://dx.doi.org/10.3390/nano11010036.

Full text

Abstract:

Prunus spinosa fruits (PSF) contain different phenolic compounds showing antioxidant and anti-inflammatory activities. Innovative drug delivery systems such as biomimetic nanoparticles could improve the activity of PSF extract by promoting (i) the protection of payload into the lipidic bilayer, (ii) increased accumulation to the diseased tissue due to specific targeting properties, (iii) improved biocompatibility, (iv) low toxicity and increased bioavailability. Using membrane proteins extracted from human monocyte cell line THP-1 cells and a mixture of phospholipids, we formulated two types o

APA, Harvard, Vancouver, ISO, and other styles

32

Pisoni, Ronald L., Brenda W. Gillespie, David M. Dickinson, Kenneth Chen, Michael H. Kutner, and Robert A. Wolfe. "The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology." American Journal of Kidney Diseases 44 (November 2004): 7–15. http://dx.doi.org/10.1053/j.ajkd.2004.08.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Andreucci, Vittorio E., Rachel B. Fissell, Jennifer L. Bragg-Gresham, et al. "Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients." American Journal of Kidney Diseases 44 (November 2004): 61–67. http://dx.doi.org/10.1053/j.ajkd.2004.08.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bommer, J., J. L. Bragg-Gresham, M. A. Eichleay, W. Kleophas, R. L. Pisoni, and F. K. Port. "DOPPS-Schätzung der Auswirkungen veränderbarer Hämodialyseverfahren auf die Überlebensrate von Dialysepatienten in Deutschland." Nieren- und Hochdruckkrankheiten 37, no. 10 (2008): 545–54. http://dx.doi.org/10.5414/nhp37545.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Pisoni, Ronald L., Brenda W. Gillespie, David M. Dickinson, Kenneth Chen, Michael H. Kutner, and Robert A. Wolfe. "The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology." American Journal of Kidney Diseases 44 (November 2004): 7–15. http://dx.doi.org/10.1016/s0272-6386(04)01099-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Andreucci, Vittorio E., Rachel B. Fissell, Jennifer L. Bragg-Gresham, et al. "Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients." American Journal of Kidney Diseases 44 (November 2004): 61–67. http://dx.doi.org/10.1016/s0272-6386(04)01107-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Libardi, S., G. Bacchini, and G. Pontoriero. "La gestione dell'Accesso Vascolare nei pazienti in dialisi: il contributo dello Studio DOPPS." Giornale di Tecniche Nefrologiche e Dialitiche 22, no. 1 (2010): 27–33. http://dx.doi.org/10.1177/039493621002200107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Pegoraro, M. "La gestione dell'Accesso Vascolare nei pazienti in dialisi: il contributo dello Studio DOPPS." Giornale di Tecniche Nefrologiche e Dialitiche 22, no. 1 (2010): 34–37. http://dx.doi.org/10.1177/039493621002200108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Pegoraro, M. "La qualità di vita dei pazienti in emodialisi: dati raccolti dallo studio DOPPS." Giornale di Tecniche Nefrologiche e Dialitiche 23, no. 4 (2011): 56–59. http://dx.doi.org/10.1177/039493621102300413.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Canaud, B., J. L. Bragg-Gresham, M. R. Marshall, et al. "Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS." Kidney International 69, no. 11 (2006): 2087–93. http://dx.doi.org/10.1038/sj.ki.5000447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Tentori, Francesca. "Mineral and Bone Disorder and Outcomes in Hemodialysis Patients: Results from the DOPPS." Seminars in Dialysis 23, no. 1 (2010): 10–14. http://dx.doi.org/10.1111/j.1525-139x.2009.00676.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Jadoul, M., N. Lameire, J. L. Bragg-Gresham, M. A. Eichleay, R. L. Pisoni, and F. K. Port. "DOPPS ESTIMATE OF PATIENT LIFE YEARS ATTRIBUTABLE TO MODIFIABLE HAEMODIALYSIS PRACTICES IN BELGIUM." Acta Clinica Belgica 62, no. 2 (2007): 102–10. http://dx.doi.org/10.1179/acb.2007.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Akizawa, T., R. L. Pisoni, T. Akiba, et al. "Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS." Nephrology Dialysis Transplantation 23, no. 11 (2008): 3643–53. http://dx.doi.org/10.1093/ndt/gfn346.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Pisoni, Ronald L., Eric W. Young, Dawn M. Dykstra, et al. "Vascular access use in Europe and the United States: Results from the DOPPS." Kidney International 61, no. 1 (2002): 305–16. http://dx.doi.org/10.1046/j.1523-1755.2002.00117.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Saran, Rajiv, Jennifer L. Bragg-Gresham, Hugh C. Rayner, et al. "Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS." Kidney International 64, no. 1 (2003): 254–62. http://dx.doi.org/10.1046/j.1523-1755.2003.00064.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Xu, Hairong, Akhtar Ashfaq, Angelo Karaboyas, et al. "MP371PREVALENCE OF HYPERKALEMIA IN DOPPS: A REAL-WORLD, INTERNATIONAL COHORT OF HEMODIALYSIS PATIENTS." Nephrology Dialysis Transplantation 32, suppl_3 (2017): iii563. http://dx.doi.org/10.1093/ndt/gfx170.mp371.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tsuruta, Yuki, Kosaku Nitta, Tadao Akizawa, et al. "Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS." International Urology and Nephrology 46, no. 9 (2014): 1833–41. http://dx.doi.org/10.1007/s11255-014-0731-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Libardi, S., G. Bacchini, and G. Pontoriero. "La gestione dell'Accesso Vascolare nei pazienti in dialisi: il contributo dello Studio DOPPS." Giornale di Clinica Nefrologica e Dialisi 22, no. 1 (2018): 27–33. http://dx.doi.org/10.33393/gcnd.2010.1194.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Pegoraro, M. "La gestione dell'Accesso Vascolare nei pazienti in dialisi: il contributo dello Studio DOPPS." Giornale di Clinica Nefrologica e Dialisi 22, no. 1 (2018): 34–37. http://dx.doi.org/10.33393/gcnd.2010.1195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Pegoraro, M. "La qualità di vita dei pazienti in emodialisi: dati raccolti dallo studio DOPPS." Giornale di Clinica Nefrologica e Dialisi 23, no. 4 (2018): 56–59. http://dx.doi.org/10.33393/gcnd.2011.1502.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!